Concord Biotech standalone net profit declines 26.91% in the June 2025 quarter
Sales decline 5.47% to Rs 203.99 crore
Net profit of Concord Biotech declined 26.91% to Rs 42.57 crore in the quarter ended June 2025 as against Rs 58.24 crore during the previous quarter ended June 2024. Sales declined 5.47% to Rs 203.99 crore in the quarter ended June 2025 as against Rs 215.80 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales203.99215.80 -5 OPM %30.1037.66 -PBDT75.0391.34 -18 PBT57.2578.16 -27 NP42.5758.24 -27Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 08 2025 | 5:58 PM IST